31 related articles for article (PubMed ID: 36109444)
1. Alpha-tocopheryl succinate and doxorubicin-loaded liposomes improve drug uptake and tumor accumulation in a murine breast tumor model.
Boratto FA; Lages EB; Loures CMC; Sabino AP; Malachias A; Townsend DM; Branco De Barros AL; Miranda Ferreira LA; Amaral Leite E
Biomed Pharmacother; 2023 Sep; 165():115034. PubMed ID: 37356372
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Nanosystem Formed by DOX-Loaded Liposomes and Extracellular Vesicles from MDA-MB-231 Is Effective against Breast Cancer Cells with Different Molecular Profiles.
Paschoal Barbosa LM; Gomes ER; Barros ALB; Cassali GD; Carvalho AT; Silva JO; Pádua AL; Oliveira MC
Pharmaceutics; 2024 May; 16(6):. PubMed ID: 38931861
[TBL] [Abstract][Full Text] [Related]
3. A (Traditional Chinese Medicine) TCM-Inspired Doxorubicin Resistance Reversing Strategy: Preparation, Characterization, and Application of a Co-loaded pH-Sensitive Liposome.
Zhang X; Liu H; Li N; Li J; Wang M; Ren X
AAPS PharmSciTech; 2023 Sep; 24(7):181. PubMed ID: 37697172
[TBL] [Abstract][Full Text] [Related]
4. Effect of platelet exosomes loaded with doxorubicin as a targeted therapy on triple-negative breast cancer cells.
Uslu D; Abas BI; Demirbolat GM; Cevik O
Mol Divers; 2024 Apr; 28(2):449-460. PubMed ID: 36576666
[TBL] [Abstract][Full Text] [Related]
5. Enhanced delivery of doxorubicin for breast cancer treatment using pH-sensitive starch/PVA/g-C
Alipournazari P; Pourmadadi M; Abdouss M; Rahdar A; Pandey S
Int J Biol Macromol; 2024 Apr; 265(Pt 1):130901. PubMed ID: 38490383
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer.
Wu D; Zhao Z; Kim J; Razmi A; Wang LL; Kapate N; Gao Y; Peng K; Ukidve A; Mitragotri S
Bioeng Transl Med; 2021 Jan; 6(1):e10188. PubMed ID: 33532588
[TBL] [Abstract][Full Text] [Related]
7. A nanotherapeutic system for gastric cancer suppression by synergistic chemotherapy and immunotherapy based on iPSCs and DCs exosomes.
Li Y; Tian L; Zhao T; Zhang J
Cancer Immunol Immunother; 2023 Jun; 72(6):1673-1683. PubMed ID: 36622422
[TBL] [Abstract][Full Text] [Related]
8. Cutting-Edge HEK293T Protein-Integrated Lipid Nanostructures: Boosting Biocompatibility and Efficacy.
Park JH; Bai CZ; Kwak JH; Choi HJ; Lee D; Hong HE; Kim OH; Kim SJ
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542268
[TBL] [Abstract][Full Text] [Related]
9. ExoDS: a versatile exosome-based drug delivery platform to target cancer cells and cancer stem cells.
Paul S; Bhagat S; Dash L; Mohapatra HD; Jena S; Verma SK; Dutta A
Front Bioeng Biotechnol; 2024; 12():1362681. PubMed ID: 38903193
[TBL] [Abstract][Full Text] [Related]
10. Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application.
Yang Q; Li S; Ou H; Zhang Y; Zhu G; Li S; Lei L
J Nanobiotechnology; 2024 Jan; 22(1):41. PubMed ID: 38281957
[TBL] [Abstract][Full Text] [Related]
11. Advances in Immunomodulatory Mechanisms of Mesenchymal Stem Cells-Derived Exosome on Immune Cells in Scar Formation.
Zhao W; Zhang H; Liu R; Cui R
Int J Nanomedicine; 2023; 18():3643-3662. PubMed ID: 37427367
[TBL] [Abstract][Full Text] [Related]
12. Co-Encapsulation of Simvastatin and Doxorubicin into pH-Sensitive Liposomes Enhances Antitumoral Activity in Breast Cancer Cell Lines.
Duarte JA; Gomes ER; De Barros ALB; Leite EA
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839690
[TBL] [Abstract][Full Text] [Related]
13. Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer.
Gomes ER; Carvalho AT; Barbosa TC; Ferreira LL; Calado HDR; Sabino AP; Oliveira MC
AAPS PharmSciTech; 2022 Sep; 23(7):255. PubMed ID: 36109444
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the Antitumor Activity and Toxicity of Tumor-Derived Exosomes Fused with Long-Circulating and pH-Sensitive Liposomes Containing Doxorubicin.
Gomes ER; Souza FR; Cassali GD; Sabino AP; Barros ALB; Oliveira MC
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365075
[TBL] [Abstract][Full Text] [Related]
15. Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model.
de Oliveira Silva J; Fernandes RS; Ramos Oda CM; Ferreira TH; Machado Botelho AF; Martins Melo M; de Miranda MC; Assis Gomes D; Dantas Cassali G; Townsend DM; Rubello D; Oliveira MC; de Barros ALB
Biomed Pharmacother; 2019 Oct; 118():109323. PubMed ID: 31400669
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
[TBL] [Abstract][Full Text] [Related]
18. Highlighting the Potential Role of Exosomes as the Targeted Nanotherapeutic Carrier in Metastatic Breast Cancer.
Khera A; Alajangi HK; Khajuria A; Barnwal RP; Kumar S; Singh G
Curr Drug Deliv; 2023; 20(4):317-334. PubMed ID: 35379150
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
